StageZero Life Sciences Ltd. Share Price
Equities
SZLS
CA8525403017
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | 0.00% | 0.00% | -11.11% |
11/04 | North American Morning Briefing : Stock Futures -2- | DJ |
04/04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Sales 2021 | 5.07M 6.93M 423M | Sales 2022 | 3.8M 5.19M 316M | Capitalization | 4.49M 6.14M 375M |
---|---|---|---|---|---|
Net income 2021 | -7M -9.57M -584M | Net income 2022 | -11M -15.04M -917M | EV / Sales 2021 | 3.99 x |
Net cash position 2021 | 368K 504K 30.72M | Net Debt 2022 | 1.78M 2.44M 149M | EV / Sales 2022 | 1.65 x |
P/E ratio 2021 |
-2.2
x | P/E ratio 2022 |
-0.39
x | Employees | 40 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 79.63% |
Latest transcript on StageZero Life Sciences Ltd.
Current month | -20.00% | ||
1 month | -27.27% | ||
3 months | -11.11% | ||
6 months | -20.00% | ||
Current year | -11.11% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01/02/01 | |
Rebecca Greco
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 01/98/01 |
Garth MacRae
BRD | Director/Board Member | 90 | 01/00/01 |
Chief Executive Officer | - | 01/02/01 |
1st Jan change | Capi. | |
---|---|---|
-11.11% | 3.61M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SZLS Stock